Skip to main content

Animations

MJFF Publications

3041 - 3050 of 6456 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2025
  • 2025
  • 2021
  • Summary Details
    OPEN
    Title: Microglia ferroptosis is regulated by SEC24B and contributes to neurodegeneration
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41593-022-01221-3
    Citation Count: 327
  • Summary Details
    OPEN
    Title: The Unified Multiple System Atrophy Rating Scale: Status, Critique, and Recommendations
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29215
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Spatially resolved transcriptomics reveals genes associated with the vulnerability of middle temporal gyrus in Alzheimer’s disease
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-022-01494-6
    Citation Count: 120
  • Summary Details
    OPEN
    Title: Stability of motor-nonmotor subtype in early-stage Parkinson’s disease
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2022.1040405
    Citation Count: 7
  • Summary Details
    OPEN
    Title: The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2022.1036068
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Dementia with Lewy bodies post-mortem brains reveal differentially methylated CpG sites with biomarker potential
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s42003-022-03965-x
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Integrating multi-omics summary data using a Mendelian randomization framework
    Journal Name: Briefings in Bioinformatics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/bib/bbac376
    Citation Count: 28
  • Summary Details
    OPEN
    Title: SAGEFusionNet: An Auxiliary Supervised Graph Neural Network for Brain Age Prediction as a Neurodegenerative Biomarker
    Journal Name: Brain Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/brainsci15070752
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Discovery of N-(6-Methoxypyridin-3-yl)quinoline-2-amine Derivatives for Imaging Aggregated α-Synuclein in Parkinson’s Disease with Positron Emission Tomography
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells14141108
    Citation Count: 1
  • Summary Details
    OPEN
    Title: No Evidence for a Causal Relationship Between Cancers and Parkinson’s Disease
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3233/jpd-202474
    Citation Count: 12
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.